NCT07676045

Brief Summary

Lymphedema is a persistent and chronic swelling condition that commonly develops after breast cancer surgeries involving axillary lymph node dissection (ALND). This condition causes pain, heaviness, and swelling in the upper limb, which severely limits shoulder mobility and functional performance in daily life tasks. While manual lymphatic drainage (MLD) is widely utilized to stimulate lymphatic flow and reduce tissue swelling, the added therapeutic benefit of combining it with deep breathing exercises remains less evaluated. This study is a randomized controlled trial designed to investigate whether combining diaphragmatic breathing exercises with manual lymphatic drainage is more effective than manual lymphatic drainage alone. The main goals of this study are to determine if this combined intervention provides greater reductions in arm circumference and subjective pain levels while significantly improving upper extremity range of motion and overall functional ability in female patients recovering from a radical mastectomy.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Apr 2026Oct 2026

Study Start

First participant enrolled

April 10, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 23, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 30, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2026

Last Updated

June 30, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

June 23, 2026

Last Update Submit

June 23, 2026

Conditions

Keywords

lymphedemapost-mastectomymanual lymphatic drainagediaphragmatic breathing

Outcome Measures

Primary Outcomes (4)

  • Limb Circumference

    Upper limb edema volume will be assessed quantitatively using a sequential tape measurement protocol. Linear measurements of arm circumference will be recorded in centimeters at multiple standardized anatomical landmarks across both the affected and unaffected upper extremities to calculate overall swelling discrepancy.

    Baseline and post-intervention at 4 weeks

  • Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire

    A 30-item self-report questionnaire designed to measure physical function and symptoms in patients with musculoskeletal disorders of the upper limb. It assesses the patient's capability to perform specific functional activities, symptom severity (such as pain, tingling, and stiffness), and the social/psychological impact on daily life. Score ranges from 0 (no disability) to 100 (severe disability).

    Baseline and post-intervention at 4 weeks

  • Numeric Pain Rating Scale (NPRS)

    A subjective 11-point pain scale where patients rate their current upper extremity pain intensity on a scale from 0 to 10. A score of 0 represents 'no pain' and a score of 10 represents the 'worst possible pain.

    Baseline and post-intervention at 4 weeks

  • Shoulder Joint Range of Motion

    Active range of motion for shoulder flexion, extension, abduction, and internal/external rotation will be measured quantitatively in degrees using a standard universal goniometer to assess upper extremity functional mobility.

    Baseline and post-intervention at 4 weeks

Study Arms (2)

Group A: Control Group

ACTIVE COMPARATOR

This group will receive standard physical therapy management consisting of Transcutaneous Electrical Nerve Stimulation (TENS) for 10 minutes, active range of motion exercises for the upper limb, and gentle muscle stretching, followed by 25 to 30 minutes of specialized Manual Lymphatic Drainage (MLD). Treatment will be administered 3 times a week for a duration of 4 weeks.

Behavioral: Manual Lymphatic Drainage

Group B: Experimental Group

EXPERIMENTAL

This group will receive standard baseline physical therapy management consisting of Transcutaneous Electrical Nerve Stimulation (TENS) for 10 minutes, active range of motion exercises for the upper limb, and gentle muscle stretching, followed by 25 to 30 minutes of specialized Manual Lymphatic Drainage (MLD). Immediately following the manual therapy, participants will perform 2 minutes of structured diaphragmatic breathing exercises (controlled deep breathing in a semi-reclined position with a 4-second inhalation, abdominal expansion, and a 4-second exhalation phase). The complete protocol will be administered 3 times a week for a total duration of 4 weeks.

Behavioral: Manual Lymphatic DrainageBehavioral: Diaphragmatic Breathing Exercises

Interventions

A specialized manual therapy technique involving gentle, slow, rhythmic skin-stretching strokes directed toward functioning, unaffected proximal lymph nodes to stimulate lymphatic flow and reduce upper extremity swelling. Administered for 25 to 30 minutes per session, 3 times a week for 4 weeks.

Group A: Control GroupGroup B: Experimental Group

Structured deep breathing exercises performed in a comfortable, semi-reclined position. Participants practice controlled inhalation through the nose for 4 seconds (allowing the abdomen to expand) followed by a controlled exhalation phase and a 4-second pause before the next breath cycle. Administered for 2 minutes immediately following Manual Lymphatic Drainage, 3 times a week for a total duration of 4 weeks.

Group B: Experimental Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female participants are eligible for enrollment because this clinical trial evaluates specialized physical therapy protocols for upper limb lymphedema secondary to a radical mastectomy, a surgical procedure performed for breast cancer management in this specific population.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients aged 18 to 65 years.
  • Patients diagnosed with unilateral upper limb lymphedema secondary to radical mastectomy.
  • Patients with stage I or stage II lymphedema.
  • Patients who provide written informed consent to participate in the study

You may not qualify if:

  • Patients with bilateral upper limb lymphedema.
  • Presence of active, recurrent, or metastatic cancer.
  • Acute skin infections or cellulitis in the affected upper extremity.
  • Severe cardiac conditions, congestive heart failure, or unstable deep vein thrombosis (DVT).
  • Patients who have undergone specialized physical therapy or manual lymphatic drainage for lymphedema within the past 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Femwell Physiotherapy Clinic

Lahore, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Breast Cancer LymphedemaLymphedema

Interventions

Manual Lymphatic Drainage

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsDrainagePhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2026

First Posted

June 30, 2026

Study Start

April 10, 2026

Primary Completion (Estimated)

October 10, 2026

Study Completion (Estimated)

October 10, 2026

Last Updated

June 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared outside of the primary research team to maintain patient confidentiality and privacy. The final study results will only be available as aggregated data through the final thesis publication.

Locations